# Efficacy and Safety Study on bIAP

> **NCT01010724** · PHASE3 · COMPLETED · sponsor: **Catharina Ziekenhuis Eindhoven**

## Conditions studied

- Coronary Artery Disease
- Endotoxin-mediated Complications From Cardiopulmonary Bypass Surgery

## Interventions

- **DRUG:** bIAP
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01010724
- **Lead sponsor:** Catharina Ziekenhuis Eindhoven
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01010724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01010724, "Efficacy and Safety Study on bIAP". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01010724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*